Social Factors Associated with the Risk of Glaucoma Suspect Conversion to Glaucoma: Analysis of the Nationwide All of Us Program
- PMID: 38959998
- PMCID: PMC11585445
- DOI: 10.1016/j.ogla.2024.06.007
Social Factors Associated with the Risk of Glaucoma Suspect Conversion to Glaucoma: Analysis of the Nationwide All of Us Program
Abstract
Purpose: To examine social factors associated with the 5-year risk of glaucoma suspects (GS) converting to open-angle glaucoma (OAG).
Design: Retrospective cohort analysis.
Subjects: We screened for participants diagnosed with GS in the All of Us database. Cases that converted to OAG within 5 years of GS diagnosis (the "conversion group") were compared with control cases that did not convert.
Methods: Demographic, socioeconomic and health-care utilization data of the cases were extracted and compared between the conversion group and the control group. Multivariable Cox proportional hazards modeling was used to identify potential factors associated with the risk of conversion.
Main outcome measures: Hazard ratios (HRs) of significant factors associated with the risk of conversion.
Results: A total of 5274 GS participants were identified, and 786 (15%) cases converted to OAG within 5-year follow-up. The 2 groups showed significant differences in age, race, gender, employment status, income/education level, history of intraocular surgery, and health-care utilization patterns. In the multivariable model, African American/Black race (HR : 1.70 [95% confidence interval (CI), 1.44-2.00]), older age at GS diagnosis (1.17 [95% CI, 1.09-1.25]), male gender (1.30 [95% CI, 1.13-1.50], no history of recreational drug use (1.23 [1.07-1.42]), history of intraocular surgery (1.60 [95% CI, 1.02-1.53]), and having more reasons for delayed health-care access (2.27 [95% CI, 1.23-4.18]) were associated with a greater hazard of conversion, while being employed (0.71 [95% CI, 0.60-0.86]) was associated with a smaller hazard of conversion (P < 0.05 for all).
Conclusions: Several social factors were associated with the conversion from GS to OAG, which may help to identify patients at higher risk of disease progression. Future studies are needed to examine the basis for these findings and the potential interventions that could address them.
Financial disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Keywords: All of Us program; Glaucoma suspect; Health-care access and utilization; Social determinants of health; Socioeconomic factors.
Copyright © 2024 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
References
-
- Chang RT, Singh K. Glaucoma Suspect: Diagnosis and Management. Asia Pac J Ophthalmol (Phila) 2016;5(1):32–7. - PubMed
-
- Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: A Randomized Trial Determines That Topical Ocular Hypotensive Medication Delays or Prevents the Onset of Primary Open-Angle Glaucoma. Archives of Ophthalmology 2002;120(6):701–13. - PubMed
-
- Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: Baseline Factors That Predict the Onset of Primary Open-Angle Glaucoma. Archives of Ophthalmology 2002;120(6):714–20. - PubMed
MeSH terms
Grants and funding
- OT2 OD026556/OD/NIH HHS/United States
- DP5 OD029610/OD/NIH HHS/United States
- U2C OD023196/OD/NIH HHS/United States
- OT2 OD026551/OD/NIH HHS/United States
- U24 OD023121/OD/NIH HHS/United States
- OT2 OD026552/OD/NIH HHS/United States
- OT2 OD026549/OD/NIH HHS/United States
- OT2 OD025337/OD/NIH HHS/United States
- T15 LM011271/LM/NLM NIH HHS/United States
- OT2 OD025277/OD/NIH HHS/United States
- OT2 OD026555/OD/NIH HHS/United States
- OT2 OD026550/OD/NIH HHS/United States
- OT2 OD026553/OD/NIH HHS/United States
- OT2 OD023205/OD/NIH HHS/United States
- OT2 OD026557/OD/NIH HHS/United States
- OT2 OD026554/OD/NIH HHS/United States
- U24 OD023163/OD/NIH HHS/United States
- OT2 OD023206/OD/NIH HHS/United States
- U24 OD023176/OD/NIH HHS/United States
- OT2 OD026548/OD/NIH HHS/United States
- P30 EY022589/EY/NEI NIH HHS/United States
- OT2 OD025315/OD/NIH HHS/United States
- UL1 TR001442/TR/NCATS NIH HHS/United States
- R01 MD014850/MD/NIMHD NIH HHS/United States
- OT2 OD025276/OD/NIH HHS/United States
LinkOut - more resources
Full Text Sources